2-72891405-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_003124.5(SPR):c.654G>A(p.Met218Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00026 in 1,614,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M218T) has been classified as Likely benign.
Frequency
Consequence
NM_003124.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPR | NM_003124.5 | c.654G>A | p.Met218Ile | missense_variant | 3/3 | ENST00000234454.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPR | ENST00000234454.6 | c.654G>A | p.Met218Ile | missense_variant | 3/3 | 1 | NM_003124.5 | P1 | |
SPR | ENST00000498749.1 | n.599G>A | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000954 AC: 24AN: 251462Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135916
GnomAD4 exome AF: 0.000273 AC: 399AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.000260 AC XY: 189AN XY: 727248
GnomAD4 genome AF: 0.000131 AC: 20AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74340
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.654G>A (p.M218I) alteration is located in exon 3 (coding exon 3) of the SPR gene. This alteration results from a G to A substitution at nucleotide position 654, causing the methionine (M) at amino acid position 218 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Dopa-responsive dystonia due to sepiapterin reductase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 01, 2021 | - - |
Dystonic disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 31, 2022 | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 218 of the SPR protein (p.Met218Ile). This variant is present in population databases (rs150078285, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SPR-related conditions. ClinVar contains an entry for this variant (Variation ID: 574213). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at